Cantor Fitzgerald Initiates Coverage On CG Oncology with Overweight Rating, Announces Price Target of $75
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Josh Schimmer initiates coverage on CG Oncology (NASDAQ:CGON) with an Overweight rating and a price target of $75.
February 20, 2024 | 2:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald initiated coverage on CG Oncology with an Overweight rating and set a price target of $75.
The initiation of coverage by a reputable analyst with an Overweight rating and a high price target suggests a positive outlook for CG Oncology's stock. This could lead to increased investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100